June 10, 2016
Via: Kelly RedmondFrom March 2016 the first 3D printed drug approved by the FDA is officially available on the U.S. market. Aprecia Pharmaceuticals’ Spritam medication (active ingredient – Levetiracetam), destined for the treatment of partial onset, myoclonic, and primary generalized tonic-clonic seizures […]